KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |
Linden Thomas Advisory Services, LLC | 115,891 | $2,013,027 | 0.45% |
Birchview Capital, LP | 30,000 | $521,100 | 0.44% |
EAM Investors, LLC | 124,438 | $2,161,488 | 0.42% |
Tejara Capital Ltd | 35,000 | $607,950 | 0.34% |
Granahan Investment Management | 534,214 | $9,279,297 | 0.33% |
GMT CAPITAL CORP | 477,853 | $8,300,307 | 0.31% |
Baker Brothers Advisors | 2,809,577 | $48,802,352 | 0.28% |
HHLR ADVISORS, LTD. | 698,741 | $12,137,131 | 0.27% |
Soleus Capital Management, L.P. | 157,349 | $2,733,152 | 0.25% |
Virtus ETF Advisers LLC | 18,461 | $320,668 | 0.20% |
External links
This page lists KINIKSA PHARMACEUTICALS LTD's shareholders in Q3 2023. To view KINIKSA PHARMACEUTICALS LTD's shareholder history, click here.